The management of advanced gynecologic cancers remains a challenge, but the treatment landscape is changing.
Adding vistusertib to treatment with paclitaxel does not improve outcomes in patients with platinum-resistant or -refractory ovarian cancer, a phase 2 trial suggests.
Postoperative adverse events can delay chemotherapy but do not affect survival outcomes in patients with platinum-sensitive, recurrent ovarian cancer, a study suggests.
A multipronged initiative increased germline BRCA mutation testing for patients with ovarian cancer by 31%.
A larger proportion of patients with private or Medicare insurance received a diagnosis of early-stage cervical cancer.
The risk of cancer remains high for women older than 50 years with BRCA1 or BRCA2 mutations, a study suggests.
Genetic susceptibility to ovarian cancer does not modify the protective effect of frequent aspirin use on ovarian cancer risk, a study suggests.
Identifying limitations in functional reserves in the older adult leads to improved decision-making related to cardiovascular risk stratification and elective procedures.
Quality metrics for cancer screening tests vary across cancer types, but most metrics are not supported by evidence, a study suggests.
The accelerated approval for Jemperli (dostarlimab-gxly) was converted to regular approval.
Mirvetuximab soravtansine has shown activity in a phase 2 trial of biomarker-selected patients with platinum-resistant ovarian cancer.
People with type 2 diabetes have an increased risk of death from colorectal, pancreatic, liver, and endometrial cancer, compared with the general population.
The consumption of ultra-processed foods is associated with an increased risk of developing cancer and dying from it, a large study suggests.
More patients should consider having their fallopian tubes removed to prevent ovarian cancer, according to the Ovarian Cancer Research Alliance.
Purchases of over-the-counter pain and indigestion medications could be used to predict ovarian cancer months before diagnosis, a study suggests.
Postmenopausal cancer survivors have greater declines in physical function than cancer-free control individuals, a new study suggests.
Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.
Patients age 65 and older are more likely to be diagnosed with late-stage cervical cancer and have a lower rate of late-stage survival at 5 years.
Compared with the general population, survivors of gynecologic cancers have a higher risk of sexual dysfunction 1 to 5 years after cancer diagnosis.
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.